A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder

Takuya Masui, Ryota Hashimoto, Ichiro Kusumi, Katsuji Suzuki, Teruaki Tanaka, Shin Nakagawa, Tatsuyo Suzuki, Nakao Iwata, Norio Ozaki, Tadafumi Kato, Masatoshi Takeda, Hiroshi Kunugi, Tsukasa Koyama

研究成果: Article査読

23 被引用数 (Scopus)

抄録

Lithium is one of the most commonly used drugs for the treatment of bipolar disorder. To prescribe lithium appropriately to patients, predictors of response to this drug were explored, and several genetic markers are considered to be good candidates. We previously reported a significant association between genetic variations in the breakpoint cluster region (BCR) gene and bipolar disorder. In this study, we examined a possible relationship between response to maintenance treatment of lithium and Asn796Ser single-nucleotide polymorphism in the BCR gene. Genotyping was performed in 161 bipolar patients who had been taking lithium for at least 1 year, and they were classified into responders for lithium mono-therapy and non-responders. We found that the allele frequency of Ser796 was significantly higher in non-responders than in responders. Further investigation is warranted to confirm our findings.

本文言語English
ページ(範囲)204-208
ページ数5
ジャーナルProgress in Neuro-Psychopharmacology and Biological Psychiatry
32
1
DOI
出版ステータスPublished - 01-01-2008

All Science Journal Classification (ASJC) codes

  • 薬理学
  • 生物学的精神医学

フィンガープリント

「A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル